Covered recipient · General Payments record
EMILY L MILLIGAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2023
$377.95
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $335.82 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $168.38 | 9 |
| NESTLE HEALTHCARE NUTRITION INC. | $42.13 | 2 |
| Fresenius Kabi USA, LLC | $42.03 | 2 |
| Ardelyx, Inc. | $27.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.79 | 1 |
| PFIZER INC. | $18.88 | 1 |
| Ferring Pharmaceuticals Inc. | $16.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.32 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227977 | CMS |
| ABBVIE INC. | $28.20 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227981 | CMS |
| ABBVIE INC. | $28.28 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227987 | CMS |
| ABBVIE INC. | $24.56 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227991 | CMS |
| ABBVIE INC. | $27.64 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227995 | CMS |
| ABBVIE INC. | $9.01 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006227999 | CMS |
| ABBVIE INC. | $9.37 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006228003 | CMS |
| ABBVIE INC. | $1.03 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006228009 | CMS |
| ABBVIE INC. | $12.97 | 08/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006228013 | CMS |
| Ardelyx, Inc. | $27.94 | 09/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053002165 | CMS |
| Ferring Pharmaceuticals Inc. | $16.67 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044305598 | CMS |
| Fresenius Kabi USA, LLC | $15.86 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060093179 | CMS |
| Fresenius Kabi USA, LLC | $26.17 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060093181 | CMS |
| NESTLE HEALTHCARE NUTRITION INC. | $21.96 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012444987 | CMS |
| NESTLE HEALTHCARE NUTRITION INC. | $20.17 | 09/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012487649 | CMS |
| PFIZER INC. | $18.88 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049583219 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.79 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055966761 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.